Evidence map›Paper›PMID 40277845›Full record

ArticleHematology reports2025

Successful Management of Acquired von Willebrand Syndrome Associated with Monoclonal Gammopathy of Undetermined Significance After Sotorasib Treatment in a Patient with Non-Small-Cell Lung Carcinoma.

Mélissa Julien, Léa Pierre, Anne-Cécile Gérout, Laurent Sattler, Olivier Feugeas, Dominique Desprez

Abstract readCase Reports
In one paragraph

Article in Hematology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mélissa JulienCentre de Ressources et Compétences des Maladies Hémorragiques Constitutionnelles, Hôpitaux Universitaires de Strasbourg, 67 091 Strasbourg, France.ORCID 0009-0005-6373-7928
Léa PierreCentre de Ressources et Compétences des Maladies Hémorragiques Constitutionnelles, Hôpitaux Universitaires de Strasbourg, 67 091 Strasbourg, France.
Anne-Cécile GéroutService de Pharmacie, Hôpitaux Universitaires de Strasbourg, 67 091 Strasbourg, France.
Laurent SattlerLaboratoire D'hématologie, Hôpitaux Universitaires de Strasbourg, 67 091 Strasbourg, France.ORCID 0000-0003-2702-6246
Olivier FeugeasCentre de Ressources et Compétences des Maladies Hémorragiques Constitutionnelles, Hôpitaux Universitaires de Strasbourg, 67 091 Strasbourg, France.
Dominique DesprezCentre de Ressources et Compétences des Maladies Hémorragiques Constitutionnelles, Hôpitaux Universitaires de Strasbourg, 67 091 Strasbourg, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acquired von Willebrand diseasecase reporttyrosine kinase inhibitor

Identifiers

PMID40277845
PMCPMC12027059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.